annual CFI:
-$109.71M+$113.92M(+50.94%)Summary
- As of today (September 16, 2025), AKRO annual cash flow from investing activities is -$109.71 million, with the most recent change of +$113.92 million (+50.94%) on December 31, 2024.
- During the last 3 years, AKRO annual CFI has fallen by -$151.99 million (-359.48%).
- AKRO annual CFI is now -359.48% below its all-time high of $42.28 million, reached on December 31, 2021.
Performance
AKRO Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
$79.34M+$561.52M(+116.45%)Summary
- As of today (September 16, 2025), AKRO quarterly cash flow from investing activities is $79.34 million, with the most recent change of +$561.52 million (+116.45%) on June 30, 2025.
- Over the past year, AKRO quarterly CFI has increased by +$335.24 million (+131.00%).
- AKRO quarterly CFI is now at all-time high.
Performance
AKRO quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$314.50M+$335.24M(+51.60%)Summary
- As of today (September 16, 2025), AKRO TTM cash flow from investing activities is -$314.50 million, with the most recent change of +$335.24 million (+51.60%) on June 30, 2025.
- Over the past year, AKRO TTM CFI has dropped by -$3.55 million (-1.14%).
- AKRO TTM CFI is now -558.77% below its all-time high of $68.55 million, reached on June 30, 2022.
Performance
AKRO TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
AKRO Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +50.9% | +131.0% | -1.1% |
| 3 y3 years | -359.5% | +568.4% | -558.8% |
| 5 y5 years | -53.4% | +106.3% | -699.7% |
AKRO Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -359.5% | +50.9% | at high | +116.5% | -558.8% | +51.6% |
| 5 y | 5-year | -359.5% | +50.9% | at high | +116.5% | -558.8% | +51.6% |
| alltime | all time | -359.5% | +50.9% | at high | +116.5% | -558.8% | +51.6% |
AKRO Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $79.34M(-116.5%) | -$314.50M(-51.6%) |
| Mar 2025 | - | -$482.18M(-3257.3%) | -$649.74M(+492.2%) |
| Dec 2024 | -$109.71M(-50.9%) | $15.27M(-79.1%) | -$109.71M(-2.2%) |
| Sep 2024 | - | $73.07M(-128.6%) | -$112.19M(-63.9%) |
| Jun 2024 | - | -$255.90M(-542.4%) | -$310.96M(+69.6%) |
| Mar 2024 | - | $57.85M(+352.4%) | -$183.36M(-18.0%) |
| Dec 2023 | -$223.62M(+250.4%) | $12.79M(-110.2%) | -$223.62M(-33.8%) |
| Sep 2023 | - | -$125.70M(-2.0%) | -$337.85M(+61.5%) |
| Jun 2023 | - | -$128.30M(-829.4%) | -$209.16M(+203.2%) |
| Mar 2023 | - | $17.59M(-117.3%) | -$68.98M(+8.1%) |
| Dec 2022 | -$63.83M(-251.0%) | -$101.44M(-3481.5%) | -$63.83M(-228.6%) |
| Sep 2022 | - | $3.00M(-74.7%) | $49.62M(-27.6%) |
| Jun 2022 | - | $11.87M(-47.8%) | $68.55M(+48.9%) |
| Mar 2022 | - | $22.75M(+89.6%) | $46.03M(+8.9%) |
| Dec 2021 | $42.28M | $12.00M(-45.3%) | $42.28M(-12.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $21.93M(-305.9%) | $48.18M(-243.4%) |
| Jun 2021 | - | -$10.65M(-156.1%) | -$33.60M(-316.5%) |
| Mar 2021 | - | $19.00M(+6.2%) | $15.52M(-259.0%) |
| Dec 2020 | -$9.76M(-86.4%) | $17.90M(-129.9%) | -$9.76M(-90.2%) |
| Sep 2020 | - | -$59.84M(-255.6%) | -$99.17M(+152.2%) |
| Jun 2020 | - | $38.47M(-712.4%) | -$39.33M(-49.4%) |
| Mar 2020 | - | -$6.28M(-91.2%) | -$77.79M(+8.8%) |
| Dec 2019 | -$71.51M(+1330.3%) | -$71.51M(<-9900.0%) | -$71.51M(<-9900.0%) |
| Sep 2019 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2019 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2019 | - | $0.00(0.0%) | -$5.00M(0.0%) |
| Dec 2018 | -$5.00M(<-9900.0%) | $0.00(0.0%) | -$5.00M(0.0%) |
| Sep 2018 | - | $0.00(-100.0%) | -$5.00M(0.0%) |
| Jun 2018 | - | -$5.00M(<-9900.0%) | -$5.00M(<-9900.0%) |
| Mar 2018 | - | $0.00 | $0.00 |
| Dec 2017 | $0.00 | - | - |
FAQ
- What is Akero Therapeutics, Inc. annual cash flow from investing activities?
- What is the all time high annual CFI for Akero Therapeutics, Inc.?
- What is Akero Therapeutics, Inc. annual CFI year-on-year change?
- What is Akero Therapeutics, Inc. quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Akero Therapeutics, Inc.?
- What is Akero Therapeutics, Inc. quarterly CFI year-on-year change?
- What is Akero Therapeutics, Inc. TTM cash flow from investing activities?
- What is the all time high TTM CFI for Akero Therapeutics, Inc.?
- What is Akero Therapeutics, Inc. TTM CFI year-on-year change?
What is Akero Therapeutics, Inc. annual cash flow from investing activities?
The current annual CFI of AKRO is -$109.71M
What is the all time high annual CFI for Akero Therapeutics, Inc.?
Akero Therapeutics, Inc. all-time high annual cash flow from investing activities is $42.28M
What is Akero Therapeutics, Inc. annual CFI year-on-year change?
Over the past year, AKRO annual cash flow from investing activities has changed by +$113.92M (+50.94%)
What is Akero Therapeutics, Inc. quarterly cash flow from investing activities?
The current quarterly CFI of AKRO is $79.34M
What is the all time high quarterly CFI for Akero Therapeutics, Inc.?
Akero Therapeutics, Inc. all-time high quarterly cash flow from investing activities is $79.34M
What is Akero Therapeutics, Inc. quarterly CFI year-on-year change?
Over the past year, AKRO quarterly cash flow from investing activities has changed by +$335.24M (+131.00%)
What is Akero Therapeutics, Inc. TTM cash flow from investing activities?
The current TTM CFI of AKRO is -$314.50M
What is the all time high TTM CFI for Akero Therapeutics, Inc.?
Akero Therapeutics, Inc. all-time high TTM cash flow from investing activities is $68.55M
What is Akero Therapeutics, Inc. TTM CFI year-on-year change?
Over the past year, AKRO TTM cash flow from investing activities has changed by -$3.55M (-1.14%)